traumatic hemorrhagic shock
Conditions
Interventions
Intervention group:Intraosseous catheterization
Control group:Central venous catheterization
Sponsors
First Affiliated Hospital of Suzhou University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Ages between 18 and 75 years, gender not specified; 2. Clinically diagnosed with severe traumatic hemorrhagic shock (manifested by altered consciousness, tachycardia, pale and cold skin, decreased blood pressure, etc.), and in need of urgent rescue; 3. Time from injury to presentation does not exceed 6 hours, vital signs are unstable, and meet the relevant diagnostic criteria for traumatic hemorrhagic shock according to the "Chinese Emergency Expert Consensus on the Diagnosis and Treatment of Traumatic Hemorrhagic Shock," namely: shock combined with hypotension (systolic blood pressure < 90 mmHg, pulse pressure difference < 20 mmHg, or a decrease in systolic blood pressure = 40 mmHg from baseline in those with pre-existing hypertension); 4. No other severe complications, such as serious heart disease, cerebrovascular disease, malignant tumors, etc.; 5. The patient or their family signs an informed consent form, agreeing to participate in this study and adhere to the research protocol; 6. Other conditions deemed suitable for participation in this study by the researchers.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications for catheter placement, such as lower limb deformities, tibial fractures, right-sided pneumothorax, etc.; 2. Pregnant or lactating women; 3. Patients known to be allergic to the study medication or infusion materials; 4. Patients with severe coagulation disorders who cannot undergo intraosseous infusion; 5. Patients with severe infections, sepsis, or other conditions that may lead to intraosseous infection; 6. Patients who have received other treatments or medications that may affect the results of this study prior to its commencement; 7. Other conditions deemed inappropriate for participation in this study by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First-time puncture success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of punctures;Catheterization time;Time taken to establish the infusion access;Success rate of treatment within 4 hours;In-hospital mortality rate; | — |
Countries
China
Contacts
Public ContactYang Peng
First Affiliated Hospital of Suzhou University
Outcome results
None listed